• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促黄体生成素分泌型垂体瘤:生物合成特征及临床研究。

Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies.

作者信息

Klibanski A, Deutsch P J, Jameson J L, Ridgway E C, Crowley W F, Hsu D W, Habener J F, Black P M

出版信息

J Clin Endocrinol Metab. 1987 Mar;64(3):536-42. doi: 10.1210/jcem-64-3-536.

DOI:10.1210/jcem-64-3-536
PMID:3102541
Abstract

Although gonadotropin-secreting pituitary adenomas are increasingly recognized, tumors secreting only LH are rare. Since gonadotropin production by pituitary adenomas may reflect imbalanced glycoprotein biosynthesis, we studied tumor LH and subunit biosynthesis and secretion in a patient with a LH- and alpha-subunit-producing pituitary tumor. Northern blot analysis of RNA from the tumor revealed the presence of mRNAs encoding both alpha- and beta-subunits of LH with a marked excess of the mRNA encoding LH beta. Analysis of tumor extracts by gel filtration chromatography confirmed an excess of free LH beta relative to free alpha-subunit. Clinical studies demonstrated that the secretion of LH and alpha-subunit by the tumor increased in response to the acute administration of LHRH (100 micrograms, iv) and decreased during a 4-h dopamine infusion (4 micrograms/kg X min). During a 4-week course of LHRH analog (D-Trp6-Pro9-NEt-LHRH) administration, given as a daily sc dose (8 micrograms/kg X day), serum LH and alpha-subunit concentrations increased 7- and 3-fold, respectively, consistent with a chronic agonist effect. Chronic administration of bromocriptine resulted in reduction of serum LH and alpha-subunit levels to normal.

摘要

尽管分泌促性腺激素的垂体腺瘤越来越受到认可,但仅分泌促黄体生成素(LH)的肿瘤却很罕见。由于垂体腺瘤产生的促性腺激素可能反映糖蛋白生物合成失衡,我们研究了一例产生LH和α亚基的垂体肿瘤患者肿瘤中LH及其亚基的生物合成与分泌情况。对肿瘤RNA进行Northern印迹分析显示,存在编码LH的α和β亚基的mRNA,其中编码LHβ的mRNA明显过量。通过凝胶过滤色谱法分析肿瘤提取物证实,相对于游离α亚基,游离LHβ过量。临床研究表明,急性静脉注射促性腺激素释放激素(LHRH,100微克)后,肿瘤分泌的LH和α亚基增加,而在4小时多巴胺输注(4微克/千克×分钟)期间则减少。在给予促性腺激素释放激素类似物(D-色氨酸6-脯氨酸9-乙基-LHRH)为期4周的疗程中,每日皮下注射剂量为8微克/千克×天,血清LH和α亚基浓度分别增加了7倍和3倍,这与慢性激动剂作用一致。长期服用溴隐亭可使血清LH和α亚基水平降至正常。

相似文献

1
Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies.促黄体生成素分泌型垂体瘤:生物合成特征及临床研究。
J Clin Endocrinol Metab. 1987 Mar;64(3):536-42. doi: 10.1210/jcem-64-3-536.
2
Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.促性腺激素和α亚基对糖蛋白激素分泌型垂体瘤患者长期给予促性腺激素释放激素类似物的反应。
J Clin Endocrinol Metab. 1989 Jan;68(1):81-6. doi: 10.1210/jcem-68-1-81.
3
The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.促黄体生成素释放激素(LHRH)激动剂[D-色氨酸6-脯氨酸9-乙基]LHRH在一名分泌促黄体生成素(LH)的垂体肿瘤患者中升高而非降低了LH和α亚基水平。
J Clin Endocrinol Metab. 1984 Feb;58(2):313-9. doi: 10.1210/jcem-58-2-313.
4
Gonadotropin-releasing hormone agonists are unsuccessful in reducing tumoral gonadotropin secretion in two patients with gonadotropin-secreting pituitary adenomas.促性腺激素释放激素激动剂在两名分泌促性腺激素的垂体腺瘤患者中未能成功降低肿瘤促性腺激素的分泌。
J Clin Endocrinol Metab. 1988 Jul;67(1):180-5. doi: 10.1210/jcem-67-1-180.
5
Effect of luteinizing hormone releasing hormone (LHRH) and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide on alpha-subunit and LH beta messenger ribonucleic acid levels in rat anterior pituitary cells in culture.促黄体生成激素释放激素(LHRH)和[D-色氨酸6,去甘氨酰胺(10)]LHRH乙酰胺对培养的大鼠垂体前叶细胞中α亚基和促黄体生成素β信使核糖核酸水平的影响。
Mol Endocrinol. 1988 Jun;2(6):521-7. doi: 10.1210/mend-2-6-521.
6
Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas.人垂体腺瘤中促卵泡激素β亚基激素生物合成失衡。
J Clin Endocrinol Metab. 1992 Jun;74(6):1343-51. doi: 10.1210/jcem.74.6.1375599.
7
Modulation by sex steroids and [D-Trp6, Des-Gly-NH2(10)]luteinizing hormone (LH)-releasing hormone ethylamide of alpha-subunit and LH beta messenger ribonucleic acid levels in the rat anterior pituitary gland.性类固醇和[D-色氨酸6,去甘氨酰胺(10)]促黄体生成激素(LH)释放激素乙酰胺对大鼠垂体前叶α亚基和LHβ信使核糖核酸水平的调节作用。
Mol Endocrinol. 1988 Sep;2(9):775-84. doi: 10.1210/mend-2-9-775.
8
Dopaminergic regulation of alpha-subunit secretion and messenger ribonucleic acid levels in alpha-secreting pituitary tumors.分泌α亚基的垂体肿瘤中多巴胺能对α亚基分泌及信使核糖核酸水平的调节
J Clin Endocrinol Metab. 1988 Jan;66(1):96-102. doi: 10.1210/jcem-66-1-96.
9
Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary.促性腺激素释放激素(GnRH)受体基因的表达在正常和去势大鼠垂体中,以与促性腺激素β亚基基因类似的方式被GnRH激动剂脱敏所改变。
Endocrinology. 1995 Jul;136(7):2803-8. doi: 10.1210/endo.136.7.7789305.
10
Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.男性使用促黄体生成素释放激素激动剂类似物进行长期治疗期间的促性腺激素和类固醇分泌模式。
J Clin Endocrinol Metab. 1984 May;58(5):862-7. doi: 10.1210/jcem-58-5-862.

引用本文的文献

1
A Bridge Too Far? Towards Medical Therapy for Clinically Nonfunctioning Pituitary Tumors.《欲速则不达?探索临床无功能垂体瘤的医学治疗方法》
Int J Mol Sci. 2025 Jun 19;26(12):5898. doi: 10.3390/ijms26125898.
2
Updating the Landscape for Functioning Gonadotroph Tumors.更新功能性腺瘤的现状。
Medicina (Kaunas). 2022 Aug 8;58(8):1071. doi: 10.3390/medicina58081071.
3
Successful pregnancy after operation in an infertile woman caused by luteinizing hormone-secreting pituitary adenoma: case report and literature review.
促黄体生成素腺瘤导致不孕妇女手术后成功妊娠:病例报告及文献复习。
BMC Endocr Disord. 2021 Jan 12;21(1):15. doi: 10.1186/s12902-020-00677-3.
4
A review on the diagnosis and treatment of patients with clinically nonfunctioning pituitary adenoma by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.巴西内分泌与代谢学会神经内分泌学部门关于临床无功能垂体腺瘤患者诊断与治疗的综述
Arch Endocrinol Metab. 2016 Aug;60(4):374-90. doi: 10.1590/2359-3997000000179.
5
Testicular "hyperstimulation" syndrome: a case of functional gonadotropinoma.睾丸“过度刺激”综合征:一例功能性促性腺激素瘤病例。
Case Rep Endocrinol. 2014;2014:194716. doi: 10.1155/2014/194716. Epub 2014 Jan 28.
6
Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas.促性腺激素分泌型和无功能垂体腺瘤的药物治疗
Pituitary. 2002;5(2):89-98. doi: 10.1023/a:1022312530900.
7
Cabergoline modulation of alpha-subunits and FSH secretion in a gonadotroph adenoma.卡麦角林对促性腺激素腺瘤中α亚基和促卵泡激素分泌的调节作用
J Endocrinol Invest. 2000 Jul-Aug;23(7):463-6. doi: 10.1007/BF03343756.
8
Receptor imaging in the diagnosis and treatment of pituitary tumors.垂体瘤诊断与治疗中的受体显像
J Endocrinol Invest. 1999 Jan;22(1):80-8. doi: 10.1007/BF03345484.
9
Gonadotropin-releasing hormone receptor mRNA expression by human pituitary tumors in vitro.人垂体肿瘤体外促性腺激素释放激素受体mRNA表达
J Clin Invest. 1994 Jun;93(6):2332-9. doi: 10.1172/JCI117238.
10
Usefulness of thyrotropin-releasing hormone test, SMS 201-995, and bromocriptine in the diagnosis and treatment of gonadotropin-secreting pituitary adenomas.促甲状腺激素释放激素试验、SMS 201-995及溴隐亭在促性腺激素分泌型垂体腺瘤诊断和治疗中的应用价值。
J Endocrinol Invest. 1994 Feb;17(2):99-104. doi: 10.1007/BF03347693.